BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#339 of 347

Vernon Bernardino

HC Wainwright & Co. · Equity Research Analyst
EstablishedRating since 2020No new ratings since Apr 2025

Analyst rating accuracy & track record

Vernon Bernardino is an equity research analyst at HC Wainwright & Co.. Bullish Whales has scored 90 of their stock calls across 18 companies. Their picks beat their sector 14% of the time over the next 12 months, and their price targets were reached 12% of the time within a year.

Win % vs sector
14%
PT Hit % (12mo)
12%
Avg sector-excess
−37.7%
Scored calls
90
Tickers
18
Tier
Established

Track record

Bullish Whales has scored 90 of Vernon Bernardino's stock calls across 18 companies, dating back to 2020. Their rated stocks beat their own sector 14% of the time over the next 12 months. On a typical call, a Bernardino pick returned −37.7% more than its sector over the following year.

Of the scored calls, 90 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Apr 2025+29.5%Miss
GOVXGeoVax Labs Inc
Buy$8.00Apr 2025−104.2%Miss
CADLCandel Therapeutics Inc
Buy$19.00Apr 2025−14.5%Miss
PHIOPhio Pharmaceuticals Corp
Buy$4.00Apr 2025−25.4%Hit
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Apr 2025+58.5%Miss
MBRXMoleculin Biotech Inc
Buy$8.00Mar 2025−93.5%Miss
MBRXMoleculin Biotech Inc
Buy$8.00Mar 2025−93.6%Miss
CADLCandel Therapeutics Inc
Buy$19.00Mar 2025−48.2%Miss
EDSAEdesa Biotech Inc
Buy$21.00Mar 2025+144.2%Miss
AEMDAethlon Medical Inc
Buy$7.00Mar 2025−102.0%Miss
ENVBEnveric Biosciences Inc
Buy$10.00Mar 2025−95.2%Miss
ARTLArtelo Biosciences Inc
Buy$5.00Mar 2025−87.2%Miss
MBRXMoleculin Biotech Inc
Buy$8.00Mar 2025−99.2%Miss
CADLCandel Therapeutics Inc
Buy$19.00Feb 2025−48.9%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Feb 2025−17.4%Miss
PHIOPhio Pharmaceuticals Corp
Buy$4.00Feb 2025−42.4%Hit
AEMDAethlon Medical Inc
Buy$7.00Feb 2025−104.5%Miss
AEMDAethlon Medical Inc
Buy$7.00Jan 2025−102.7%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Dec 2024−37.9%Miss
CADLCandel Therapeutics Inc
Buy$19.00Dec 2024−59.3%Miss
ARTLArtelo Biosciences Inc
Buy$5.00Dec 2024−78.0%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Nov 2024−45.9%Miss
GOVXGeoVax Labs Inc
Buy$8.00Nov 2024−92.2%Miss
CADLCandel Therapeutics Inc
Buy$11.00Nov 2024+5.8%Hit
GOVXGeoVax Labs Inc
Buy$8.00Nov 2024−95.3%Miss
AEMDAethlon Medical Inc
Buy$7.00Nov 2024−95.7%Miss
DYAIDyadic International Inc
Buy$6.00Nov 2024−28.2%Miss
ARTLArtelo Biosciences Inc
Buy$5.00Nov 2024−79.8%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Oct 2024−38.1%Miss
EDSAEdesa Biotech Inc
Buy$21.00Aug 2024−36.8%Miss
ARTLArtelo Biosciences Inc
Buy$5.00Aug 2024+36.3%Miss
GOVXGeoVax Labs Inc
Buy$8.00Aug 2024−60.3%Hit
DYAIDyadic International Inc
Buy$6.00Jul 2024−27.1%Miss
EDSAEdesa Biotech Inc
Buy$21.00Jun 2024−48.3%Miss
AEMDAethlon Medical Inc
Buy$7.00Jun 2024−60.4%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Jun 2024−29.6%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Jun 2024−42.4%Miss
ARTLArtelo Biosciences Inc
Buy$5.00Jun 2024−15.5%Miss
ARTLArtelo Biosciences Inc
Buy$5.00May 2024−21.7%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00May 2024−41.7%Miss
PHIOPhio Pharmaceuticals Corp
Buy$4.00May 2024−63.7%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Apr 2024−43.1%Miss
ARTLArtelo Biosciences Inc
Buy$5.00Apr 2024−43.6%Miss
AEMDAethlon Medical Inc
Buy$10.00Mar 2024−77.6%Miss
EDSAEdesa Biotech Inc
Buy$21.00Feb 2024−44.9%Miss
PHIOPhio Pharmaceuticals Corp
Buy$4.00Feb 2024−67.0%Miss
ENVBEnveric Biosciences Inc
Buy$10.00Jan 2024−66.8%Miss
MBRXMoleculin Biotech Inc
Buy$3.00Dec 2023−80.1%Miss
EDSAEdesa Biotech Inc
Buy$21.00Nov 2023−40.1%Miss
EDSAEdesa Biotech Inc
Buy$10.00Nov 2023−46.7%Miss
Go to

Vernon Bernardino: analyst track record FAQ

Is Vernon Bernardino a good stock analyst?

Yes, by track record. Vernon Bernardino ranks number 339 of 347 of the analysts Bullish Whales scores, with a BW Score of 0 out of 100. Past results do not guarantee future ones.

What is Vernon Bernardino's win rate?

Vernon Bernardino's win rate is 14%. Across 90 scored calls, their rated stocks beat their sector 14% of the time over the next 12 months. On a typical call they returned −37.7% more than the sector.

What stocks and sectors does Vernon Bernardino cover?

Vernon Bernardino covers 18 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Vernon Bernardino's price targets accurate?

Vernon Bernardino's price targets are reached within 12 months 12% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Vernon Bernardino's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Vernon Bernardino rank among Wall Street analysts?

Vernon Bernardino ranks number 339 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30